Cornerstone Investment Partners, LLC Entrada Therapeutics, Inc. Transaction History
Cornerstone Investment Partners, LLC
- $1.93 Billion
- Q1 2025
A detailed history of Cornerstone Investment Partners, LLC transactions in Entrada Therapeutics, Inc. stock. As of the latest transaction made, Cornerstone Investment Partners, LLC holds 10,943 shares of TRDA stock, worth $99,909. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,943
Previous 11,889
7.96%
Holding current value
$99,909
Previous $205,000
52.2%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding TRDA
# of Institutions
104Shares Held
27.8MCall Options Held
40.3KPut Options Held
4.1K-
Baker Bros. Advisors LP New York, NY4.87MShares$44.4 Million0.93% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA4.41MShares$40.2 Million33.83% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.38MShares$40 Million60.89% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.9MShares$26.5 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X02.08MShares$19 Million0.02% of portfolio
About Entrada Therapeutics, Inc.
- Ticker TRDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,368,500
- Market Cap $286M
- Description
- Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...